Literature DB >> 33648668

Neurobiological aspects of pain in the context of alcohol use disorder.

Jessica A Cucinello-Ragland1, Scott Edwards2.   

Abstract

Alcohol is an effective and widely utilized analgesic. However, the chronic use of alcohol can actually facilitate nociceptive sensitivity over time, a condition known as hyperalgesia. Excessive and uncontrollable alcohol drinking is also a hallmark feature of alcohol use disorder (AUD). Both AUD and chronic pain are typically accompanied by negative affective states that may underlie reinforcement mechanisms contributing to AUD maintenance or progression. Frequent utilization of alcohol to relieve pain in individuals suffering from AUD or other chronic pain conditions may thus represent a powerful negative reinforcement construct. This chapter will describe ties between alcohol-mediated pain relief and potential exacerbation of AUD. We describe neurobiological systems engaged in alcohol analgesia as well as systems recruited in the development and maintenance of AUD and hyperalgesia. Although few effective therapies exist for either chronic pain or AUD, the common interaction of these conditions will likely lead the way for promising new discoveries of more effective and even simultaneous treatment of AUD and co-morbid hyperalgesia. An abundance of neurobiological findings from multiple laboratories has implicated a potentiation of central amygdala (CeA) signaling in both pain and AUD, and these data also suggest that attenuation of stress-related systems (including corticotropin-releasing factor, vasopressin, and glucocorticoid receptor activity) would be particularly effective and comprehensive therapeutic strategies targeting the critical intersection of somatic and motivational mechanisms driving AUD, including alcohol-induced hyperalgesia.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Central amygdala; Corticotropin-releasing factor; Dependence; Glucocorticoids; Hyperalgesia; Negative affect; Negative reinforcement; Pain; Vasopressin

Mesh:

Year:  2020        PMID: 33648668      PMCID: PMC8356551          DOI: 10.1016/bs.irn.2020.09.001

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  175 in total

1.  Feeling no pain: alcohol as an analgesic.

Authors:  Kenneth M Woodrow; Lorne G Eltherington
Journal:  Pain       Date:  1988-02       Impact factor: 6.961

2.  G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action.

Authors:  J M Lewohl; W R Wilson; R D Mayfield; S J Brozowski; R A Morrisett; R A Harris
Journal:  Nat Neurosci       Date:  1999-12       Impact factor: 24.884

3.  Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.

Authors:  David A Katz; Wei Liu; Charles Locke; Sandeep Dutta; Katherine A Tracy
Journal:  Psychopharmacology (Berl)       Date:  2015-09-26       Impact factor: 4.530

4.  Hemispheric lateralization of pain processing by amygdala neurons.

Authors:  Guangchen Ji; Volker Neugebauer
Journal:  J Neurophysiol       Date:  2009-07-22       Impact factor: 2.714

5.  Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats.

Authors:  Ami Cohen; Jennifer Treweek; Scott Edwards; Rodrigo Molini Leão; Gery Schulteis; George F Koob; Olivier George
Journal:  Addict Biol       Date:  2013-07-22       Impact factor: 4.280

6.  Psychogenic facial pain: presentation and treatment.

Authors:  C Feinmann
Journal:  J Psychosom Res       Date:  1983       Impact factor: 3.006

7.  Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception.

Authors:  Vera Combs Campbell; Robert Emory Taylor; Yousef Tizabi
Journal:  Alcohol Clin Exp Res       Date:  2007-06-05       Impact factor: 3.455

8.  Prevalence and impact of depression and pain in neurology outpatients.

Authors:  L S Williams; W J Jones; J Shen; R L Robinson; M Weinberger; K Kroenke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

9.  Relationships among pain, anxiety, and depression in primary care.

Authors:  Adrienne J Means-Christensen; Peter P Roy-Byrne; Cathy D Sherbourne; Michelle G Craske; Murray B Stein
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

10.  Depression as a psychopathological disorder in chronic low back pain patients.

Authors:  R D France; J L Houpt; A Skott; K R Krishnan; I M Varia
Journal:  J Psychosom Res       Date:  1986       Impact factor: 3.006

View more
  3 in total

Review 1.  The Convergent Neuroscience of Affective Pain and Substance Use Disorder.

Authors:  Amanda R Pahng; Scott Edwards
Journal:  Alcohol Res       Date:  2021-12-16

2.  Alcohol amplifies cingulate cortex signaling and facilitates immobilization-induced hyperalgesia in female rats.

Authors:  Jessica A Cucinello-Ragland; Roshaun Mitchell-Cleveland; W Bradley Trimble; Amy P Urbina; Alice Y Yeh; Kimberly N Edwards; Patricia E Molina; Liz Simon Peter; Scott Edwards
Journal:  Neurosci Lett       Date:  2021-07-17       Impact factor: 3.197

Review 3.  Pathophysiological Consequences of At-Risk Alcohol Use; Implications for Comorbidity Risk in Persons Living With Human Immunodeficiency Virus.

Authors:  Liz Simon; Scott Edwards; Patricia E Molina
Journal:  Front Physiol       Date:  2022-01-18       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.